James Nataro headshot
JN

James P. Nataro

Professor
Unit: School of Medicine
Department: Department of Pediatrics
Office location and address
81 Hospital Dr
Charlottesville, Virginia 22903
Education
MD, Medicine, University of Maryland
MBA, Business, University of Maryland
PhD, Microbiology, University of Maryland
Biography

Dr. James Nataro came to UVA in September 2010, and he currently serves as the physician in chief for UVA Children's Hospital and the chair of the Department of Pediatrics. He is an attending physician in inpatient general pediatrics, and until recently, pediatric infectious diseases. His research focuses on intestinal health, especially diseases of developing countries. He's also involved in teaching upcoming healthcare professionals.

With everything that he does, Dr. Nataro’s ultimate goal is to improve the health of children.

Test the efficacy of CfaE-based anti-colonizing antibodies
Source: Lumen Bioscience, Inc.
June 01, 2019 – May 31, 2024
MD-PEDT-Project 1: Pathogenesis of E. coli and Shigella infections in human enteroid models
Source: University Of Maryland
July 01, 2016 – June 30, 2021
HMO Identification & Synthesis
Source: University of California, San Diego
April 10, 2017 – April 30, 2020
Purification of EPEC and EAEC Fimbrial Antigens
Source: Humabs Biomed SA
November 29, 2017 – November 28, 2019
lmmunophrophylactic Strategies to Control Emerging Enteric Infections YR05
Source: University Of Maryland
March 01, 2018 – February 28, 2019
ENTVAC Consortium Phase II
Source: University Of Maryland
October 04, 2016 – October 03, 2018
lmmunophrophylactic Strategies to Control Emerging Enteric Infections YR04
Source: University Of Maryland
March 01, 2017 – February 28, 2018
Protocol 03-CPP-HIS-300 Efficacy & Safety of Histrelin Subdermal Implant
Source: Valera Pharmaceuticals, Inc.
August 01, 2004 – December 17, 2017
MD-PEDT Host, Pathogens and Pathogen Interaction Determinants of Environmental Enteric Dysfunction
Source: Bill & Melinda Gates Foundation
November 30, 2015 – November 30, 2017
Enteric Dysfunction Biomarker Development and Coordination II
Source: Washington University, The
October 05, 2016 – September 30, 2017
MD-PEDT Enteric Pathogens and Relationship to Pathogenesis of Gut Inflammation in the GEMS Cases and Controls
Source: Bill & Melinda Gates Foundation
July 09, 2015 – June 30, 2017
MD-PEDT Immunophrophylactic Strategies to control emergin enteric infections
Source: University Of Maryland
March 01, 2016 – February 28, 2017
A Toxoid Vaccine Against Heat-stable Enterotoxin of E. coli
Source: University Of Maryland
September 01, 2010 – June 30, 2016
Virulence in Enteroaggregative Escherichia Coli
Source: U.S. NIH Institute of Allergy & Infectious Disease
April 01, 2011 – March 31, 2016
MD-PEDT Immunophrophylactic Strategies to Control Emerging Enteric Infections
Source: University Of Maryland
March 01, 2015 – February 29, 2016
MD-PEDT A Citrobacter Rodentium Model E Coli DIarrhea
Source: Bill & Melinda Gates Foundation
May 01, 2014 – October 31, 2015
MD-PEDT Enteric Dysfunction Biomarker Development and Coordination
Source: Washington University, The
November 05, 2012 – September 30, 2015
MD-PEDT Sever Enteric Disease: Pathogenesis and Response
Source: University Of Maryland
July 01, 2014 – June 30, 2015
MD-PEDT Immunoprophylactic Strategies to Control Emerging Enteric Infections
Source: University Of Maryland
March 01, 2014 – February 28, 2015
Metagenomics Based Discovery of New Viral and Eukaryotic Pathogens causing Diarrheal Disease
Source: University Of Maryland
January 01, 2011 – October 31, 2014
MD-PEDT Severe Enteric Disease: Pathogenesis and Response
Source: University Of Maryland
July 01, 2013 – June 30, 2014
Protocol MS205 IGFD Registry
Source: Tercica, Inc.
January 11, 2008 – January 10, 2014
A Phase II Multi-Center Double-Blind Trial
Source: Pharmacia & Upjohn Company
September 01, 1997 – December 31, 2013
Enhancing Childrens & Parents Asthma Management
Source: The University of Texas at Austin
December 01, 2008 – November 30, 2013
Influenza Vaccine Effectiveness in High Risk Children
Source: Abt Associates, Inc.
September 22, 2010 – September 30, 2013
Progress in Reducing Developmental and Behavioral Co-morbidities of Asthma in Children with Emphasis on Health Disparities Risk Factors
Source: U.S. Health Resources & Services Administration
September 01, 2010 – August 31, 2013
Severe ENteric Disease: Pathogenesis and Response
Source: University Of Maryland
July 01, 2012 – June 30, 2013
Natural History Study of the Development of Type 1 Diabetes
Source: University of South Florida
March 30, 2010 – June 30, 2013
MD-PEDT S-nitrosothiol biology in ventilatory regulation
Source: Case Western Reserve University
April 01, 2013 – June 21, 2013
Diarrheal disease in infants and young children in developing countries
Source: University Of Maryland
May 31, 2012 – May 30, 2013
S-nitrosothiol Breakdown by Airway Epithelial Cells
Source: U.S. NIH Heart, Lung, And Blood Institute
June 15, 2008 – April 30, 2013
MD-PEDT Cellular S-Nitrosothiol Signaling in Repiratory Biology
Source: Case Western Reserve University
January 23, 2013 – March 31, 2013
MD-PEDT Cellular S-Nitrosothiol Signaling in Respiratory Biology
Source: Case Western Reserve University
January 23, 2013 – February 28, 2013
MICR 9995: Research in Microbiology, Immunology and Infectious Diseases
Credits: 1–12
Research in microbiological related disciplines, e.g. cancer, immunology, bacteriology, virology, infectious diseases, cell signaling, nuclear transport, host-pathogen interactions, gene expression, etc.
MICR 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.